Cargando…
PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis
We recently showed that melatonin ameliorates the severity of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. However, efficiency of melatonin therapy was associated with side effects, manifested by slowing down of remyelination, through increasing the inhibitory effects of b...
Autores principales: | Ghareghani, Majid, Farhadi, Zahra, Rivest, Serge, Zibara, Kazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959827/ https://www.ncbi.nlm.nih.gov/pubmed/35355991 http://dx.doi.org/10.3389/fimmu.2022.862316 |
Ejemplares similares
-
Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis
por: Ghareghani, Majid, et al.
Publicado: (2019) -
Melatonin and vitamin D, two sides of the same coin, better to land on its edge to improve multiple sclerosis
por: Ghareghani, Majid, et al.
Publicado: (2023) -
Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis
por: Ghareghani, Majid, et al.
Publicado: (2023) -
Author Correction: Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis
por: Ghareghani, Majid, et al.
Publicado: (2023) -
Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway
por: Ghareghani, Majid, et al.
Publicado: (2018)